Ethical considerations explored for aducanumab in Alzheimer’s disease
Nov 19, 2021
Grounds are insufficient to offer aducanumab (Aduhelm) for moderate, advanced Alzheimer’s dementia or for individuals without biomarker evidence of brain ß-amyloid, according to a position statement.
Higher pancreatic fat percentage linked to lower cognition in men
Feb 27, 2024
Higher pancreatic fat was linked to lower cognition and brain volumes in middle-aged men at high risk for Alzheimer’s disease.
Genetic links seen for HDL cholesterol, systolic BP with Alzheimer’s disease
May 17, 2023
Genetically determined high-density lipoprotein cholesterol and systolic blood pressure were linked to increased odds of Alzheimer’s disease.
Early-onset Alzheimer’s disease patients in rural areas lack specialty care
Aug 09, 2022
Rural patients are more likely to receive a diagnosis and treatment from primary care providers.
Gantenerumab does not slow clinical decline in early Alzheimer’s disease
Nov 16, 2023
Two trials show a lower amyloid plaque burden with gantenerumab versus placebo at 116 weeks.
Interventions for Alzheimer’s disease improve cognition in men, women
May 03, 2022
Individualized multidomain interventions are equally effective for improving cognition in women and men.
Bladder cancer treatment may lower risk for Alzheimer’s and related dementias
Jun 12, 2023
A greater effect was seen for patients aged 70 years and older at time of bacillus Calmette-Guerin vaccination.
Study identifies factors that predict driving cessation in seniors
May 22, 2024
Older age, female sex and progression to symptomatic Alzheimer’s disease were associated with driving cessation.
Excess Alzheimer’s, related dementia-linked mortality increased during COVID-19
Jul 19, 2023
Among nursing home/long-term care residents, pandemic-era ADRD-related excess deaths decreased from 34,259 in year 1 to 22,050 in year 2, but excess deaths at home remained high (34,487 and 28,804, respectively).
Sleep-disordered breathing linked to medial temporal lobe atrophy in seniors
Jun 02, 2023
Higher sleep apnea severity was related to lower medial temporal lobe subregion volumes in amyloid-positive, but not amyloid-negative, individuals.